BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 3 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 4 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 5 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 17 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 17 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 20 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 22 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 24 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 3 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 4 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 5 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 17 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 17 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 20 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 22 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 24 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 day ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago
ADVERTISEMENT
AlphaGraphs

PG Earnings: Key quarterly highlights from Procter & Gamble’s Q4 2023 financial results

The Procter & Gamble Company (NYSE: PG) reported fourth quarter 2023 earnings results today. Net sales increased 5% year-over-year to $20.6 billion. Organic sales rose 8%. Net earnings attributable to Procter & Gamble grew 11% to $3.4 billion while EPS rose 13% to $1.37 compared to last year. Core EPS rose 13% to $1.37. Both revenue […]

July 28, 2023 1 min read

The Procter & Gamble Company (NYSE: PG) reported fourth quarter 2023 earnings results today.

Net sales increased 5% year-over-year to $20.6 billion. Organic sales rose 8%.

Net earnings attributable to Procter & Gamble grew 11% to $3.4 billion while EPS rose 13% to $1.37 compared to last year. Core EPS rose 13% to $1.37.

Both revenue and earnings beat expectations allowing the stock to gain over 1% in premarket hours on Friday.  

The company expects all-in sales growth of 3-4% for FY2024. Organic sales are expected to grow 4-5%.

ADVERTISEMENT

Prior performance

ADVERTISEMENT